Correlation Between Catalyst Pharmaceuticals and New Era

Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and New Era at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and New Era into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Pharmaceuticals and New Era Helium, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and New Era and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of New Era. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and New Era.

Diversification Opportunities for Catalyst Pharmaceuticals and New Era

0.01

Correlation Coefficient

Catalyst Pharmaceuticals  New Era

Significant diversification

The 3 months correlation between Catalyst and New is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and New Era Helium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on New Era Helium and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with New Era. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of New Era Helium has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and New Era go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and New Era

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 0.8 times more return on investment than New Era. However, Catalyst Pharmaceuticals is 1.25 times less risky than New Era. It trades about 0.02 of its potential returns per unit of risk. New Era Helium is currently generating about -0.01 per unit of risk. If you would invest  2,105  in Catalyst Pharmaceuticals on October 4, 2024 and sell it today you would earn a total of  47.00  from holding Catalyst Pharmaceuticals or generate 2.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Catalyst Pharmaceuticals  vs.  New Era Helium

Catalyst Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in February 2025.

New Era Helium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days New Era Helium has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Catalyst Pharmaceuticals and New Era

The main advantage of trading using opposite Catalyst Pharmaceuticals and New Era positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, New Era can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in New Era will offset losses from the drop in New Era's long position.

The idea behind Catalyst Pharmaceuticals and New Era Helium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.